RARA CRAFT DATABASE for FDA Medical Devices
510(k)K250809

FDA DEVICE FACTS

Stellar M22

Lumenis Be, Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 16, 2025PRODUCT CODEGEX

Indications for use

The Lumenis Stellar M22 system has connection capability with the following available treatment modules, for multi-application treatment options. All modules are designed for aesthetic and dermatological skin procedure application, as follows: IPL with a spectrum of 400-1200nm (with different filters) is indicated for:

• B enign epidermal lesions, i ncluding dyschromia, hyperpigmentation, melasma and ephelides (freckles).

• Cutaneous lesions, includi ng w arts, scars and striae.

• Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations.

• Removal of unwanted hair from all skin types, and to effect stable long term, or permanent hair reduction* in skin types I-V through selective targeting of melanin in hair follicles.

• Mild to moderate i nflammatory Acne (Acne Vulgaris). Multi-Spot Nd:YAG Laser, with a wavelength of 1064 nm is indicated for:

• The coagulation and hem ostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm diameter) of the leg.

• The non-ablative treatm ent of fac ial wrinkles.

• The removal of unwanted hai r from all skin types, and to effect stable long term, or permanent hair reduction* in skin types I-V through selective targeting of melanin in hair follicles. The 1565nm ResurFX module, with a wavelength of 1565 nm, is indicated for:

• Use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue. Q-Switched Nd:YAG Laser, wi th a w avelength of 1064 nm, is indicated for:

• Treatment of pigmented l esions.

• Removal of dark tattoos. *Note: Permanent hair reduction i s defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regimen.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026